Belmar Pharmacy
“Prescriptions issued by clinicians on the platform are dispensed by the following US-licensed partner pharmacies: Belmar Pharmacy - 800-525-9473 - belmarpharmasolutions.com”
Source: www.pallashealth.co · Verified 2026-08-07
Pallas Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 8.1/10
Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found
8.1
★★★★☆4.1/5
Pallas Health scores highest on state availability and ease of access.
$139first month
then $199/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
See plans →See plans at Pallas Health →
No insurance needed · Vetted by our editors
Pallas Health is a telehealth platform operated by Brentmoor, Inc. offering compounded semaglutide and tirzepatide alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro. Compounded plans average $199 and $299 a month with provider care, check-ins and messaging included and no separate membership fee, and the price stays the same at every dose. Its clinical disclosures page is unusually complete: two named advising physicians with verifiable NPIs, the clinical partner Lion MD, six named partner pharmacies, and coverage in all 50 states plus DC.
By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Names 6 partner pharmaciesNamed MDs with NPIsAll 50 states plus DCFlat price at every doseBrand GLP-1s availableNo membership feeFSA/HSA eligibleFree expedited shipping
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Pallas Health at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $139/mo ($139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.)
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Pallas Health
Each dimension is scored algorithmically from Pallas Health’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $199/mo, Pallas Health runs about 18% above the $169 median for GLP-1 providers, and the first-month promo drops to $139. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
8.5/10Pallas Health offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.8/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
9.0/10Key details fully confirmed by our editors; no FDA warning letters on file; discloses which pharmacy makes its medication (last checked 2026-08-07).
Accessibility10%
9.1/10Pallas Health treats patients in all 50 states. FSA/HSA cards are accepted.
Support10%
6.3/10Pallas Health provides standard clinician follow-up; no extended coaching or community program is disclosed.
6scored dimensions
573providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Pallas Health review
Last checked August 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Verified the compounding pharmacy partner and its accreditation
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: high.
What to expect when you sign up with Pallas Health
We walked Pallas Health’s public signup flow in August 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Read the public pricing, which states the first-month and 12-week figures for both drugs before any account
- 2Start a visit and complete an online intake; medication ships only when a clinician prescribes
- 3A Lion MD clinician licensed in your state reviews the intake, plus a synchronous video visit where state law requires one
- 4In video-visit states checkout collects a $60 deposit instead of the full first payment, credited toward the first order
- 5On approval the balance is charged and the subscription begins, anchored to the approval date
Price shown before you start
- Both the first-month price and the recurring 12-week charge are published on the homepage and the GLP-1 treatment page.
- The clinical disclosures page names the provider network, both advising physicians with NPIs, all six partner pharmacies and the states served.
- Pallas cites Massachusetts, Rhode Island and Vermont telemedicine rules as the reason it publishes clinician information publicly.
- Under the charge-on-approval checkout you are not charged the full amount until a clinician approves; a declined plan refunds the deposit in full.
- The homepage "200,000+ patients" figure is hard to reconcile with the clinical page's reference to a July 2026 launch and waitlist patients.
GLP-1 medications Pallas Health offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Pallas Health offers
Beyond GLP-1s, Pallas Health also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Compounded plan, billed $597 every 12 weeks (not monthly)Compounded
$199$139/mo
Save 30% right nowsemaglutide
$139 for the first month, then $597 every 12 weeks, which Pallas advertises as a $199/mo average. Same price at every dose. Provider care and check-ins included.
Compounded plan, billed $897 every 12 weeks (not monthly)Compounded
$299$179/mo
Save 40% right nowtirzepatide
$179 for the first month, then $897 every 12 weeks, advertised as a $299/mo average. Same price at every dose.
Ready to get started?
Plans and promotions change often — check Pallas Health's current pricing and active discounts before you decide.
Pallas Health compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Pallas Health routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
Strive Pharmacy
“Strive Pharmacy - 855-405-5993 - strivepharmacy.com”
Source: www.pallashealth.co · Verified 2026-08-07
Epiq Scripts
“Epiq Scripts - 833-654-3553 - epiqscripts.com”
Source: www.pallashealth.co · Verified 2026-08-07
Casa Pharma Rx
“Casa Pharma Rx - 877-937-6868 - casapharmarx.com”
Source: www.pallashealth.co · Verified 2026-08-07
The Pharmacy Hub
- License footprint
- 1 states: FL
“The Pharmacy Hub - 888-958-1382 - thepharmacyhub.com”
Source: www.pallashealth.co · Verified 2026-08-07
Foothills Pharmacy
“Foothills Pharmacy - 480-496-4444 - foothillspharmacy.com”
Source: www.pallashealth.co · Verified 2026-08-07
What we like
- Names six partner pharmacies with phone numbers and websites, the most complete pharmacy disclosure we have recorded.
- Publishes two advising physicians with NPI numbers you can verify yourself in the federal NPPES registry.
- Price stays the same at every dose, and provider care, check-ins and messaging are included with no membership fee.
- Offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro alongside compounded options, and serves all 50 states plus DC.
Watch-outs
- Billed $597 every 12 weeks, not monthly; at 4.33 cycles a year the true cost is about $216/mo, above the $199 advertised.
- The homepage claims "200,000+ patients" while the clinical page describes a July 2026 launch and existing waitlist patients.
- Cancelling after a payment deducts third-party processing costs plus a $5 fee per refunded payment.
- In states requiring a live video visit a $60 deposit is taken at checkout, and it may be retained if you abandon the intake.
Is Pallas Health worth it? Our verdict
Pallas Health positions itself around one thing: the most complete public disclosure of pharmacies and prescribing physicians we have found. New patients start at $139 in month one, but the price settles at $199/month after that — so the headline is a trial offer, not the standing rate. Its flat, all-dose pricing is a genuine plus for anyone worried about cost climbing as they titrate up.
Pallas Health rounds out its offering with Names 6 partner pharmacies, Named MDs with NPIs, and All 50 states plus DC.
How much Pallas Health actually costs
- Compounded semaglutide — $139 first month, then $199/month
- Compounded tirzepatide — $179 first month, then $299/month
For context, the typical ongoing price across the GLP-1 providers we track is around $169/month, so Pallas Health's standing rate sits at the premium end. The first-month discount is a great way to start cheaply, but price out the ongoing rate against a flat-rate provider before you commit long term.
For a direct comparison, RNK Health runs semaglutide and tirzepatide from $197/month — worth pricing against Pallas Health before you commit.
Medications: what Pallas Health prescribes
Pallas Health prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Who Pallas Health is best for — and who should skip it
A good fit if you…
- want the cheapest possible way to start a GLP-1 and see how you respond before committing.
- live anywhere in the US and want guaranteed access.
Look elsewhere if you…
- want the lowest total cost over 6–12 months — a flat-rate provider like bmiMD will likely beat the ongoing price.
- specifically want an FDA-approved brand-name pen.
- need to bill insurance — like most of this market, it's cash-pay.
Trust, safety, and medical oversight
Pallas Health treats patients in all 50 states, and names the pharmacy that fills its prescriptions. We found no FDA warning letters on file for the provider. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Pallas Health is one of the easiest ways to start a GLP-1 cheaply — just go in clear-eyed that the $139 intro price steps up to $199/month. Use the first month to confirm the medication works for you, then re-check the ongoing math before you settle in. If you're comparison-shopping, Breeze Meds is one of the closest alternatives we track — worth a look before deciding.
The Bottom Line
Pallas Health scores highest on state availability and ease of access.
Score: 8.1/10Best for: the most complete public disclosure of pharmacies and prescribing physicians we have foundFrom: $139/mo
Ready to start with Pallas Health?
Starting at $139/month. See current pricing and start your free consultation.
Pallas Health might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider ShedRx.
Alternatives to Pallas Health
★★★★☆4/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →★★★★☆4/5
Editorial score · methodology
$149/mo
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →★★★★☆4.1/5
Editorial score · methodology
$99/mo
CompoundedSemaglutideTirzepatideGlutathioneNAD+
Get StartedRead full bmiMD review →Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Pallas Health review:
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Pallas Health's current pricing
Plans start at $139/month. Start your free consultation to check eligibility and today's price.
From $139/mo
Pallas Health